Novavax (NVAX) PT Raised to $61 at B.Riley/FBR, Following Acquisition Of Praha Vaccines
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.14 +2.26%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
B.Riley/FBR analyst Mayank Mamtani raised the price target on Novavax (NASDAQ: NVAX) to $61.00 (from $53.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
- Asia Vital Components Co Ltd (3017:TT) PT Raised to NT$4,250 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
